HLA-G and colorectal carcinoma: HLA-G aberrant expressions have been observed in a variety of human cancers including cutaneous melanoma, mesothelioma, glioma, hematopoietic and trophoblastic tumors; lymphoproliferative disorders and carcinoma of lung, ovary, endometrium, bladder, breast, kidney, gastric and colorectal carcinoma.